Site Editors

Case Series of NTRK-Rearranged Spindle Cell Neoplasms Offers Clinical Insights

Factors to Consider When Developing Laboratory Algorithms for NTRK Fusion Testing

Genetic Abnormalities as Therapeutic Targets in Cholangiocarcinomas

Strategies for Screening Gastrointestinal Stromal Tumors for NTRK Gene Fusions

Testing a Drug in Tumors With Actionable Genetic Biomarkers: Update on Basket Trials

Genomic Landscape of Secretory Breast Carcinomas and NTRK Fusion

NTRK-Rearranged Spindle Cell Neoplasms: New Insights on Histopathology

Employing Aminopyrimidine Derivatives as TRK Inhibitors

Intestinal LMNA::NTRK1-Fused Spindle Cell Neoplasm: Case Report

Working Toward Molecular Actionability in Kinase Fusion–Related Thyroid Carcinomas

ALK Fusion–Positive Neoplasms Can Mimic NTRK-Rearranged Spindle Cell Tumors

Targeted Therapy for NSCLC Based on Genetic Rearrangements

Case Report: NTRK-1–Associated Lipofibromatosis-Like Neural Tumor

Targetable Biomarkers May Be Worth Identifying in Pancreatic and Liver Cancers: Expert Consensus From Spain

Dutch Team Examines the Cost-Effectiveness of Entrectinib in NTRK-Positive Cancer

Spinal Cord Low-Grade Gliomas in Pediatric Patients: Uncovering Rare Genetic Alterations

Educating Patients About Tumor Genomic Testing: Gaps and Opportunities for Improvement

Diagnosing and Treating NTRK Fusion–Positive Tumors: Expert Consensus From China

Role of Tumor Suppressor Gene Count in Predicting the Biology of Translocation-Defined Tumors

Can Molecular Profiling Guide Diagnostic Assessment of Indeterminate Pediatric Thyroid Nodules?

Earlier Use of Larotrectinib in Mismatch Repair–Deficient TRK Fusion–Positive Metastatic Colon Cancer

Case Report: Effect of Larotrectinib Treatment on Infant-Type Hemispheric Glioma With TPR::NTRK1 Fusion

Tropomyosin Receptor Kinases: A Potential Target for Tumors With NTRK Gene Fusions

Case Study of Larotrectinib in Mismatch Repair–Deficient TRK Fusion–Positive Colorectal Cancer

Are NTRK2 Fusions a Targetable Treatment Alternative in Deep-Seated Pediatric Astrocytoma?

Is Pan-TRK Immunohistochemistry Effective in Detecting NTRK Rearrangements in Thyroid Cancer?

High-Grade Glioma With NTRK Fusion Responds to Larotrectinib: Case Report

Frequency and Clinicopathologic Characteristics of NTRK Gene Fusion–Positive Sarcomas

Ongoing Clinical Trial Evaluates Efficacy and Safety of TRK Inhibitor Larotrectinib

Frequency of NTRK Fusions in Gastrointestinal Stromal Tumors

Enhancing the Diagnostic Accuracy of Secretory Carcinoma of the Salivary Gland

Clinical Outcomes With Larotrectinib in Patients Who Have TRK Fusion–Positive Thyroid Cancer

How Often Are Oncologists Testing for NTRK Gene Fusion and Using Results to Modify Treatment?

Brain Metastasis Model of NTRK-Rearranged Tumors: Focus on Treatment Resistance

RET/NTRK Fusions and Risk of Metastasis in Pediatric Differentiated Thyroid Cancer

NTRK Gene Fusions in Undifferentiated Sarcomas in Pediatric Patients

Age-Dependent Biologic Consequences of NTRK and RET Gene Fusions in Thyroid Cancer

TRK Mutations: How to Find Them and Target Therapy for Select Solid Tumors

Rapid Multiplex RNA-Based Assay Under Study in Detection of Genetic Rearrangements and Alterations

Is Pan-TRK Immunohistochemistry the Optimal Way to Identify NTRK Gene Fusions in Brain Tumors?

Researchers Identify Key Regulator of NTRK Fusion Pathway Activation in Thyroid Cancer

Screening for NTRK Fusions in Glioblastomas: FISH Versus IHC

Use of TRK Inhibitors in Pediatric Patients With Cancers Harboring NTRK Fusions

Examining the Influence of NTRK Gene Fusions in Solid Tumors

Rare Case of TPM3-NTRK Rearrangement in Recurrent Ovarian Cancer

Long-Term Update on Entrectinib for NTRK Fusion–Positive Solid Tumors

Novel Therapeutics for NTRK Fusion–Positive Infantile Fibrosarcoma

Histologic Characterization of an NTRK-Rearranged Spindle Cell Neoplasm: Case Report

Identifying Actionable Gene Fusions Using a Functional Genomic Approach

Genetic Alterations in Inflammatory Myofibroblastic Tumors

Next-Generation Sequencing Guides Treatment in Spinal Cord Tumor With NTRK Fusion: Case Report

Response to Immunotherapy in NSCLC: Beyond EGFR Mutations

Singapore Task Force: When and How to Test for NTRK Gene Fusions in Select Cancers

Cytomorphologic Features of NTRK-Mutated Papillary Thyroid Cancer

First- Versus Second-Generation TRK Inhibitors for NTRK Fusion–Positive Cancers

Next-Generation ROS1/TRK/ALK Inhibitor Under Study in Neuroblastoma

Are NTRK Fusions ‘Bona Fide’ Oncogenic Drivers of Lung Cancer?

Use of Larotrectinib for in Sarcoma of the Chest: Case Study Focused on TMTC2-NTRK3 Fusion

Lipofibromatosis-Like Neural Tumor: Case Featuring an NTRK Abnormality

Case Study: Broad Morphologic Spectrum of Mesenchymal Tumors With NTRK Fusions

Serrated Neoplasia Pathway: A Clue to NTRK-Rearranged Colorectal Tumors

Case Report: Use of FISH Signal Pattern to Confirm Secretory Carcinoma of the Salivary Gland

Pediatric Thyroid Cancer: Should Molecular Subtype Be Included in Risk Stratification?

Multitargeted Treatment Approach to Mammary Analog Secretory Carcinoma: Case Report Focuses on NTRK Fusions

Gene Fusion Testing Strategies for Colorectal, Skin, and Lung Cancers

Larotrectinib for TRK Fusion–Positive Gastrointestinal Cancer

Can NTRK Gene Fusions Influence Chromosomal Imbalances in Soft-Tissue Sarcomas?

TRK Inhibitors for NTRK Fusion–Positive Sarcoma: A Canadian Perspective

Targeting NTRK Gene Fusions in Gliomas

NTRK1-TPM3 Gene Rearrangement in Recurrent Ovarian Cancer: Case Report

How Common Are NTRK Fusions in Bone Tumors in Pediatric Patients?

Rare Case of Mesenchymal Sarcoma With NTRK1 Gene Translocation

European Pediatric Sequencing Programs: Screening for Targetable NTRK Gene Fusions

Differentiated Thyroid Cancer: Molecular Profiling for NTRK Gene Fusions in Assessing Risk for Recurrence

NTRK3 Promoter Methylation: Predictive Marker for Survival in Colorectal Cancer?

Rare Case of Mosaicism in a Glioblastoma Harboring NTRK Fusion and PDGFRA Amplification

Larotrectinib for Pediatric Undifferentiated Sarcoma With an STRN-NTRK2 Fusion: Case Study

Larotrectinib in RAI-Refractory Papillary Thyroid Cancer: Case Report

NTRK Fusion–Positive Solid Tumors: Entrectinib Granted Conditional Marketing Authorization in the European Union

Can Pan-TRK Immunohistochemistry Identify NTRK Fusions in Lung Cancer?

Case Report: Use of Larotrectinib in a Boy With TRK Fusion–Positive ALL

NTRK Fusions and Cancer: Focus on Biology and Therapeutic Targeting of These Drivers

Shedding Light on the Landscape of NTRK Aberrations in Pediatric and Adult Tumors

Novel TFG‐NTRK2 Fusion in Spitz/Reed Tumor: Case Report

Entrectinib in NTRK Fusion– and ROS1 Fusion–Positive Solid Tumors: Patient-Reported Outcomes

Identifying NTRK Gene Fusions for Targeted Therapy: ‘An Ongoing Clinical Priority’

Larotrectinib for Advanced Lung Cancer With Novel NCOR2-NTRK1 Fusion: Case Study

Study Identifies Benefits of Testing for NTRK Fusions in Thyroid Cancers

Understanding NTRK Fusion Actionability: An Overview of Targeted Therapy Options